Figure 6.
Average serum cytokine concentrations in four ALS patients who remained on thalidomide for nine months. Serum was collected prior to thalidomide treatment (baseline) and at 3, 6, and 9 months after thalidomide treatment. No cytokine had significantly higher or lower values compared to baseline values (paired t-test).